Titre:
  • Differential benefit of metronomic chemotherapy among triple negative breast cancer subtypes treated in the IBCSG Trial 22-00.
Auteur:Joaquin Garcia, Andrea; Rediti, Mattia; Venet, David; Majjaj, Samira; Kammler, Roswitha; Munzone, Elisabetta; Gianni, Lorenzo; Thürlimann, Beat; Láng, I; Colleoni, Marco Angelo; Loi, Sherene; Viale, Giuseppe; Regan, Meredith M; Buisseret, Laurence; Rothé, Françoise; Sotiriou, Christos
Informations sur la publication:Clinical cancer research
Statut de publication:Publié, 2023-09-01
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Humans
Triple Negative Breast Neoplasms -- drug therapy -- genetics -- pathology
Treatment Outcome
Disease-Free Survival
Prognosis
Chemotherapy, Adjuvant -- methods
Cyclophosphamide
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1078-0432
info:doi/10.1158/1078-0432.CCR-23-1267
info:pii/729200
info:scp/85178649440
info:pmid/37733800